Form 4: Director Kyle Ceases Insider Reporting at Sotera Health

Sotera Health Director Richard G. Kyle has filed a Form 4 indicating he is no longer subject to Section 16 reporting requirements.

Summary

• Richard G. Kyle, a Director of Sotera Health Co (SHC), has filed a Form 4 with the SEC.
• The filing explicitly states that Mr. Kyle is no longer subject to the reporting requirements of Section 16 of the Securities Exchange Act of 1934, effective February 4, 2026.
• No transactions involving the acquisition or disposition of non-derivative or derivative securities were reported in this filing.
• An associated Power of Attorney, dated February 4, 2026, grants authority to Erika Ostrowski, Sarah Kim, Michael J. Solecki, and Gregory S. Harvey to execute and file SEC forms on Mr. Kyle's behalf, which remains in effect until he is no longer required to file reports under Section 13 or 16.

Sentiment

Score: 5

Explanation: StockSavvy.ai views this as a neutral, procedural filing that simply updates the reporting status of a director and does not contain information impacting company performance or valuation.

Positives

• The filing demonstrates compliance with SEC regulations by formally notifying the cessation of Section 16 reporting obligations for a director.

Negatives

• The filing does not contain any information regarding new transactions, financial performance, or other positive developments for the company.

Future Outlook

The filing does not provide any forward-looking statements or guidance regarding Sotera Health's operations or financial performance.

Industry Context

StockSavvy.ai notes that Form 4 filings are routine disclosures for insider transactions or changes in reporting status. This specific filing, indicating a director is no longer subject to Section 16, is a procedural update rather than a reflection of broader industry trends or competitive positioning.

Stakeholder Impact

• Shareholders: Minimal direct impact, as this is a procedural filing regarding a director's reporting status and does not convey new material information about the company's operations or financial health.
• Employees, Customers, Suppliers, Creditors: No direct impact from this procedural filing.

Key Dates

Recommendation

This is a procedural SEC Form 4 filing indicating a director is no longer subject to Section 16 reporting requirements. It contains no new financial or operational information that would warrant a change in investment recommendation. Therefore, a 'hold' recommendation is appropriate as existing investment theses remain unchanged.

Keywords

Sotera Health, SHC, Form 4, SEC filing, insider reporting, beneficial ownership, director, Richard G. Kyle, corporate governance, Section 16